| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLF | Common Stock | Purchase | $498K | +61.7K | +11.39% | $8.07 | 604K | Feb 16, 2024 | Direct | F1 |
| transaction | HLF | Common Stock | Award | $0 | +496K | +82.1% | $0.00 | 1.1M | Feb 16, 2024 | Direct | F2 |
| transaction | HLF | Common Stock | Award | $0 | +84.8K | +7.72% | $0.00 | 1.18M | Feb 16, 2024 | Direct | F3 |
| transaction | HLF | Common Stock | Tax liability | -$245K | -30.4K | -2.56% | $8.07 | 1.15M | Feb 16, 2024 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLF | Stock Appreciation Rights | Award | $0 | +983K | $0.00 | 983K | Feb 16, 2024 | Common Stock | 983K | $8.07 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | This transaction represents multiple open market purchases. The range of prices for such transactions is $7.84 to $8.20. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price. |
| F2 | Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Issuer's Board of Directors (the "Board"), subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the RSU vest prior to February 16, 2025. |
| F3 | Consists of RSUs fully vested at the time of grant. |
| F4 | Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 16, 2024. |
| F5 | Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Board, subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the SAR vest prior to February 16, 2025. |